The preparation and evaluation of ethylene glycol-stabilized haemolysates for use äs control material for the assay of glycated haemoglobins is described. These haemolysates were prepared from normal and diabetic blood samples by following the procedure normally used to purify human haemoglobin, with the addition of dialysis to remove glucose from the labile fractions, and dilution with ethylene glycol. All the haemoglobin fractions were converted into the carbon monoxide form to increase their stability and were stored under different conditions. During a lOmonth period of storage at -20 °C no significant change in the glycated haemoglobins level was observed.
According to a recent report (6) , control data are | The measurement of glycated haemoglobins HbA lc satisfactory only when the thiobarbituric acid test is [ or HbAj is of great clinical importance for the long used to ineasure calibration compounds (fructose or l term monitoring of diabetic patients (l, 2). The clin-5-hydroxymethylfurfural), or affmity chromaj ical usefulness of this test is greatly enhanced when tography is used with whole blood (7) to measure the the so called "labile" fraction, i. e. the Schiff base glycated haemoglobins. Fructose or 5-hydroxymeadduct between haemoglobin and glucose, is dis-thylfurfural are easily available in the laboratory. sociated by dialysis (3), treatment with a borate buffer Although whole blood can be used directly äs control (4), or with semicarbazide (5). material (7), it can not be stored for a long time.
Some lyophilized Standards are now commercially available (from Bio-Rad Laboratories and Boehringer Mannheim) but their stability after reconstitution is very limited.
In our previous reports on quality control in haemoglobinometry (8) and on the measurements of haemoglobins A 2 and F (9) we described the preparation of some ethylene glycol-stabilized haemolysates. These were shown to be stable for more than one year when stored at -20 °C.
In this paper, a similar technique is described for the preparation of haemolysates for use äs control material for the assay of glycated haemoglobins. The following experimental steps were adopted: a) removal of the labile fraction by incubation of the haemolysate with an appropriate borate buffer; b) conversion of haemoglobin to the carbon monoxide derivative; c) dilution ofthe solution with ethylene glycol and storageat -20°C.
Materials and Methods

Preparation of the haemolysate
Haemolysates, containing normal and pathological HbA t cqncentrations, were prepared from blood samples from healthy subjects (from the blood center AVIS, Milan) and from a pool of washed red blood cells from diabetic patients, respectively. Sodium EDTA at l g/l final concentration was used äs anticoagulant. No sample with abnormal values of HbA 2 , HbF, HBsAg and/or abnormal haemoglobin bands on cellulose acetate electrophoresis at pH 8.4 or positive for HBsAg was included. All the purification work was performed in the cold room. After plasma removal, the red blood cells were washed three times with a 9.0 g/l NaCl solution and then haemolysed by addition of CC1 4 and distilled water (0.4 volumes and 1.0 volumes, respectively, per volume of red blood cells). The haemoglobin solution was then separated after centrifugation at 3000g for 30min and dialysed against 50mmol/l sodium tetraborate pH 8.9. After 4 changes of the buffer, the dialysing solution was replaced by a solution of 20 mmol/1 K 2 HPO 4 , 50 mmol/1 KC1 and 5 mmol/1 EDTA at pH 7.4. The dialysis was complete after 4 further changes of this buffer. The resulting haemoglobin solution was then concentrated with an Amicon apparatus (using PM10 membranes) up to 230 g/l and flushed with carbon monoxide in sealed vials for about 5 min.
The haemoglobin was allowed to stand overnight under an atmosphere of CO, then centrifuged at 20000 g for 40 min to remove any precipitated material. Finally, it was diluted with ethylene glycol to give a total Hb concentration of about 150 g/l in 0.35 vol/vol ethylene glycol. Small aliquots (2 ml) of this material were then distributed in sterilized sealed vials, flushed again with carbon monoxide and stored at -20°C.
HbA, and HbA lc measurements
The HbA, and HbA lc levels were determined by the commercial methods available from Bio-Rad Laboratories (Milan). All the Chromatographie runs were performed in a thermostated chamber at 23 ± 0.2°C.
Speclrophotometric analysis of haemoglobin solutions The HbCO and MetHb Contents of the haemoglobin Solutions were determined by use of a multicomponent analysis programme on the spectrophotometer Sp 601 (C. Erba, Milan). The 10 mmol/1 borate solution at pH 9.1 used for these analyses was prepared fresh each week.
The same Instrument was used to ofctain the haemoglobin •spectra.
Isoelectric focusing
Isoelectric focusing (IEF) analysis of the samples was performed on a polyacrylamide gel (12 12 0.05 cm, T = 6%, C = 4%) containing 4% of LKB ampholines (pH 6-8). The run was performed at 5 W constant power and 800 V. Stauung was done by the Comassie blue method äs described by Mälik (10).
Results
The HbAi and HbA lc levels of the normal and of the diabetic haemolysates stored at -20 °C were analysed over a 10 month period and found to be very stable.
All the analyses were performed in duplicate on the same vials. The stability was statistically assessed by means of a linear regression analysis of analytical values (y, fraction) versus time of storage (x, in days) (11) . The relevant parameters are shown in tablel. No significant differences were found between the overall mean values and the corresponding intercept values. The within run precision CV for the HbAi and HbA lc determinations were 1.7% and 2.5% respectively. For the normal sample the between run CV were 3.3% for the HbAj determinations and 7.2% for the HbA lc . For the diabetic samples they were 2.6% and 5.0%, resp'ectively.
The IEF analysis ( fig. 1 ) did not reveal significant differences among the samples, before and after about one year of storage at -20 °C. By spectrophotometric analysis, the amount of MetHb in all samples was found to be neglegible; furthermore, no trace of haemoglobin aging components (such äs HbA 3 and other, (13)) were detected.
After staining with Comassie blue the composition of the non-haemoglobin bands was also found to be unchanged in all the samples.
A third preparation from non diabetic blood was used to test the stability of HbAj and HbA lc levels during ISdays storage at -80°C, +4°C, +25°C and +37°C.
The results are shown in figure 2.
The HbCÖ and MetHb concentrations of the haemolysates stored at -20 °C were analysed on the same days that HbAi and HbA ic measurements were made. The HbCO and MetHb levels were found to be stable during storage. Över 146 days of storage, the HbCO and MetHb levels were 91.3 + 1.6% and 2.2 + 0.2% (mean ± SD), respectively.
The HbCO and MetHb were also determined in the samples stored ai -80°C, +4°C, +25°C and + 37 °C. No significative deviations from the initial values were reported during the period of storage.
To evaluate the possible use of this material in long term quality control programs for HbA! and HbA lc measurements, we stored some haemolysate at -80°<j. Under these conditions the solution freezes; we think, hpwever, that the combined effect of the ethylene glycol and the carbon monoxide can prevent the haemoglobin from autoxidation. The effects of repeated cycles of freezing and thawing on the same material were therefore studied by measuring the absorption spectra in the region 500-650 nm.
No significative changes in the initial spectrum were detected even after 16 cycles. 
Discussion
It is known that protein Solutions can be stabilized in several ways. Glycerol seems to have a powerful effect on the activity of several enzymes (12) . In the case of haemoglobin, stabilization is improved by the use of carbon monoxide, preventing the generation of methaemoglobin, which is rapidly formed after exposure at relatively warm temperatures (8) . Finally, the cold is probably a third protective agent and indeed our data demonstrate that under proper conditions of storage, the haemolysates can be maintained for long periods of time. The treatement with borate is particularly necessary to obtain haemolysates free from the "labile fractions".
A previous report by Delgado & Daza (14) described the preparation and the control of a lyophilized haemolysate which proved to be stable for Smonths after preparation. However no statistical analysis of the stability was presented. Further, the concentrations during the storage were not graphically illustrated.
We hope that the method described here will be helpful in the production of control materials for glycated haemoglobin assays, which is still, according to Goldstein (15), a very actual problem for the optimization of these analysis and for the comparison of values from clinic to clinic. As described above, we determined the two HbAi and HbA lc concentrations by means of cation exchange chromatography on Bio-Rex 70 on -Rad minicolumns. Although the real accuracy of the HbAi c method could be questionable, nevertheless the two methods are among the most commonly used in cliiiical analysis. Of course, it is important to confinn our data using pther techniques, such äs HPLC and affinity chromatography. Work is now in progress in our laboratory to test a fresh stock of haemolysate by the thiobarbituric acid test and to evaluate the long term stability of haemolysates stored at -80 °C. The results of these experiments will be presented in a future communication.
The stabilized haemolysate herein described is now being tested by a group of the Community Bureau of Reference (Commission of the Eüiropean Communities) äs suitable material for an interlaboratories test. This test will be designed to evaluate analytical variability in the glycated haemoglobin measurement.
